IL-17 and IL-22 induce IL-36 production in keratinocytes (Carrier et al, 2011; Pfaff et al, 2017) and blocking IL-36 attenuates the disease severity in a model of IL-23–induced psoriasis (Su et al, 2019). This evidence concerns the gene IL17A and psoriasis.